相关实验视频

Updated: May 25, 2025

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells

Published on: October 16, 2018

目前的问题和针对性治疗的未来前景在初级中东腔大B细胞淋巴瘤中

Athanasios Liaskas¹, Maria N Dimopoulou¹, Alexia Piperidou¹

¹Department of Hematology and Bone Marrow Transplantation, Medical School, National and Kapodistrian University of Athens, General Hospital of Athens "Laikon", 11527 Athens, Greece.

Journal of clinical medicine

|February 26, 2025

概括

主要中大B细胞淋巴瘤 (PMLBCL) 是一种罕见的癌症. 像检查点抑制剂和CAR T细胞这样的向疗法对复发性或耐火性PMLBCL有希望.

科学领域:

在瘤学瘤学.
血液学血液学血液学
免疫治疗是一种免疫疗法.

背景情况:

主要中大B细胞淋巴瘤 (PMLBCL) 是一种具有侵略性的B细胞瘤.
它与扩散性大B细胞淋巴瘤 (DLBCL) 和霍奇金淋巴瘤 (HL) 有共同的特征.
一线免疫化疗通常可以治愈,但复发的疾病可能对传统治疗不耐药.

研究的目的:

审查PMLBCL针对性治疗的最新进展.
在PMLBCL治疗算法中定义新型药物的最佳序列.
专注于治疗复发性或耐火性PMLBCL的策略.

主要方法:

对PMLBCL中的向药物最近研究的文献综述.
对临床试验数据和治疗结果的分析.
讨论免疫治疗,干细胞移植和放射治疗的作用.

主要成果:

检查点抑制剂 (CPI) 已在复发性/耐药性PMLBCL中显示出有效性.
化学抗原受体 (CAR) T细胞疗法为特定患者提供了有利的结果.
自主干细胞移植 (ASCT) 仍然是化学敏感个体的选择.

结论:

包括CPI和CAR T细胞在内的向疗法正在改变PMLBCL治疗.
这些新型药物的精确作用和序列,以及ASCT和放射治疗,需要进一步阐明.
目前正在进行研究,以优化侵袭性PMLBCL的治疗策略.

关键词:

在CAR T细胞中.布伦图西马布 (brentuximab) 在维多丁中被发现.这就是尼沃卢马布 (nivolumab).这就是Pembrolizumab.主要的中间体大B细胞淋巴瘤.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.